(Q34800265)

4 August 2017

title

A cell-based assay to assess the persistence of action of agonists acting at recombinant human beta(2) adrenoceptors (English)

1 reference

4 August 2017

Susan Summerhill

1

1 reference

4 August 2017

Timothy Stroud

2

1 reference

4 August 2017

Roshini Nagendra

3

1 reference

4 August 2017

Christelle Perros-Huguet

4

1 reference

4 August 2017

Michael Trevethick

5

1 reference

4 August 2017

publication date

2 July 2008

1 reference

Journal of Pharmacological and Toxicological Methods

4 August 2017

published in

1 reference

4 August 2017

volume

58

1 reference

4 August 2017

issue

3

1 reference

4 August 2017

page(s)

189-197

1 reference

Long-chain formoterol analogues: an investigation into the effect of increasing amino-substituent chain length on the beta2-adrenoceptor activity

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.06.003

Why are long-acting beta-adrenoceptor agonists long-acting?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.06.003

QSAR and the rational design of long-acting dual D2-receptor/beta 2-adrenoceptor agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.06.003

Influence of agonist efficacy and receptor phosphorylation on antagonist affinity measurements: differences between second messenger and reporter gene responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.06.003

Temporal characteristics of cAMP response element-mediated gene transcription: requirement for sustained cAMP production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.06.003

Salmeterol, a novel, long-acting β2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.06.003

In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.06.003

Safety, tolerability and efficacy of indacaterol, a novel once-daily beta(2)-agonist, in patients with COPD: a 28-day randomised, placebo controlled clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.06.003

Extent of salmeterol-mediated reassertion of relaxation in guinea-pig trachea pretreated with aliphatic side chain structural analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.06.003

Ultra long-acting beta 2-agonists in development for asthma and chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.06.003

High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.06.003

Skeletal muscle expresses the extracellular cyclic AMP-adenosine pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.06.003

Cloning of the cDNA for the human beta 1-adrenergic receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.06.003

Regulation of intracellular cyclic AMP in skeletal muscle cells involves the efflux of cyclic nucleotide to the extracellular compartment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.06.003

cAMP: fuel for extracellular adenosine formation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.06.003

Sustained activation of a G protein-coupled receptor via "anchored" agonist binding. Molecular localization of the salmeterol exosite within the 2-adrenergic receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.06.003

The Ile164 beta(2)-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to G(s).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.06.003

Extracellular calcium and cAMP: second messengers as "third messengers"?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.06.003

Non-competitive antagonism of beta(2)-agonist-mediated cyclic AMP accumulation by ICI 118551 in BC3H1 cells endogenously expressing constitutively active beta(2)-adrenoceptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.06.003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.06.003

Molecular mechanisms of beta(2)-adrenergic receptor function, response, and regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.06.003

cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.06.003

Effect of indacaterol, a novel long-acting beta2-agonist, on isolated human bronchi.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.06.003

Effects of beta-adrenoceptor agonists in human bronchial smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.06.003

Formoterol on airway smooth muscle and human lung mast cells: a comparison with salbutamol and salmeterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.06.003

GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.06.003

Beta-adrenoceptor agonists and asthma--100 years of development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.06.003

10.1016/J.VASCN.2008.06.003

7 January 2021

Identifiers

DOI

1 reference

4 August 2017

1 reference